Literature DB >> 8190912

Insulin-like growth factor I in human gastrointestinal exocrine secretions.

O P Chaurasia1, S P Marcuard, E R Seidel.   

Abstract

Insulin-like growth factor I (IGF-I) is the mediator of growth hormone dependent growth. The peptide has been identified by radioimmunoassay in a number of human exocrine secretions of the gastrointestinal tract including (nM): saliva 0.9, gastric juice 3.5, jejunal chyme 24.6, pancreatic juice 3.6, and bile 0.9. The identification of IGF-I in pancreatic juice was confirmed by HPLC. The intravenous injection of 1 unit/kg secretin increased pancreatic juice IGF-I content from a basal level of roughly 4 nM to nearly 20 nM. Conversely, the IGF-I content of bile was unaffected by secretin. Radioligand blot analysis of samples of gastric juice, jejunal chyme and pancreatic juice demonstrated that these fluids contained no IGF binding proteins. Thus, unlike IGF-I in serum, IGF-I secreted into the gastrointestinal lumen is not bound to insulin-like growth factor I binding proteins. Since the growth factor is not protein bound, its concentration in the gut lumen may be high enough to exert biological activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8190912     DOI: 10.1016/0167-0115(94)90026-4

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  9 in total

Review 1.  Insulin-like growth factors in the gastrointestinal tract and liver.

Authors:  John F Kuemmerle
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-15       Impact factor: 4.741

Review 2.  Adult pancreatic alpha-cells: a new source of cells for beta-cell regeneration.

Authors:  Cheng-Ho Chung; Fred Levine
Journal:  Rev Diabet Stud       Date:  2010-08-10

3.  The trophic action of growth hormone, insulin-like growth factor-I, and insulin on human duodenal mucosa cultured in vitro.

Authors:  E E Wheeler; D N Challacombe
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

4.  Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease.

Authors:  Domenico Alvaro; Paolo Onori; Gianfranco Alpini; Antonio Franchitto; Douglas M Jefferson; Alessia Torrice; Vincenzo Cardinale; Fabrizio Stefanelli; Maria Grazia Mancino; Mario Strazzabosco; Mario Angelico; Adolfo Attili; Eugenio Gaudio
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

5.  Characterization and growth regulation of a rat intrahepatic bile duct epithelial cell line under hormonally defined, serum-free conditions.

Authors:  P C de Groen; B Vroman; K Laakso; N F LaRusso
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

6.  Novel roles of local insulin-like growth factor-1 activation in gastric ulcer healing: promotes actin polymerization, cell proliferation, re-epithelialization, and induces cyclooxygenase-2 in a phosphatidylinositol 3-kinase-dependent manner.

Authors:  Tom Nguyen; Jianyuan Chai; Aihua Li; Tomohiko Akahoshi; Tetsuya Tanigawa; Andrzej S Tarnawski
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

7.  Administration of insulin-like growth factor-I (IGF-I) peptides for three days stimulates proliferation of the small intestinal epithelium in rats.

Authors:  C B Steeb; J F Trahair; L C Read
Journal:  Gut       Date:  1995-11       Impact factor: 23.059

8.  Insulin-like growth factor I in suckling rat gastric contents.

Authors:  H A Olanrewaju; E D Sanzenbacher; E R Seidel
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

9.  Jejunal microvilli atrophy and reduced nutrient transport in rats with advanced liver cirrhosis: improvement by Insulin-like Growth Factor I.

Authors:  Inma Castilla-Cortázar; María Pascual; Elena Urdaneta; Javier Pardo; Juan Enrique Puche; Bárbara Vivas; Amelia Díaz-Casares; María García; Matías Díaz-Sánchez; Isabel Varela-Nieto; Alberto Castilla; Salvador González-Barón
Journal:  BMC Gastroenterol       Date:  2004-06-14       Impact factor: 3.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.